Il semble qu'il y ait eu une erreur en essayant de charger cette page.
Notre équipe a été informée mais veuillez nous contacter en utilisant le widget support email si le problème persiste.
| Trend | Peers | Company |
|---|---|---|
| Is return on equity increasing? | Yes | No |
| Is net profit margin increasing? | Yes | No |
| Is asset turnover increasing? | Yes | No |
| Is equity multiplier increasing? | Yes | Yes |
| Competitors Used |
|---|
| Aprogen Biologics Inc. |
| Ildong Pharmaceutical Co., Ltd. |
| KOREA PHARMA Co., Ltd. |
| CMG Pharmaceutical Co., Ltd. |
| Kyongbo Pharmaceutical Co., Ltd |
| Return on Equity Benchmarks | ||||||||
| Comparable Companies | ||||||||
| A003060 | A249420 | A032300 | A058820 | A214390 | A002390 | |||
| Return On Equity | ||||||||
| Latest Twelve Months | -28% | -3% | 5% | 1% | 3% | -17% | ||
| Fiscal Year - 1 | -30% | -44% | 0% | 3% | 2% | -8% | ||
| Fiscal Year - 2 | 3% | -82% | -2% | 0% | 0% | 3% | ||
| Fiscal Year - 3 | 2% | -49% | 12% | NA | -5% | 1% | ||
| Fiscal Year - 4 | 3% | -5% | 9% | NA | 6% | 7% | ||
| Fiscal Year - 5 | -4% | -5% | 23% | 2% | 4% | 11% | ||
| Average | -9% | -31% | 8% | 2% | 2% | 0% | ||
| Median | -1% | -24% | 7% | 2% | 3% | 2% | ||
| Benchmarks | Ticker | |||||||
| Aprogen Biologics Inc. | KOSE:A003060 | |||||||
| Ildong Pharmaceutical Co., Ltd. | KOSE:A249420 | |||||||
| KOREA PHARMA Co., Ltd. | KOSDAQ:A032300 | |||||||
| CMG Pharmaceutical Co., Ltd. | KOSDAQ:A058820 | |||||||
| Kyongbo Pharmaceutical Co., Ltd | KOSE:A214390 | |||||||
| Financial Performance | ||||||||
| Comparable Companies | ||||||||
| (in millions) | A003060 | A249420 | A032300 | A058820 | A214390 | A002390 | ||
| Latest Fiscal Year | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
| LTM Period | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
| Revenues | ||||||||
| Latest Twelve Months | 67,378 | 614,941 | 81,277 | 99,100 | 238,556 | 507,358 | ||
| Fiscal Year | 67,378 | 614,941 | 81,277 | 99,100 | 238,556 | 507,358 | ||
| Fiscal Year - 1 | 87,364 | 600,758 | 83,240 | 93,907 | 216,357 | 522,741 | ||
| Fiscal Year - 2 | 65,190 | 637,714 | 81,029 | 82,197 | 196,265 | 543,759 | ||
| Fiscal Year - 3 | 56,482 | 560,132 | 79,577 | NA | 170,660 | 517,641 | ||
| Fiscal Year - 4 | 53,320 | 561,845 | 71,510 | NA | 215,285 | 503,612 | ||
| Fiscal Year - 5 | 50,904 | 517,468 | 66,136 | 58,623 | 191,706 | 473,000 | ||
| Net Income | ||||||||
| Latest Twelve Months | (104,979) | (4,576) | 3,792 | 2,695 | 4,639 | (52,563) | ||
| Fiscal Year | (104,979) | (4,576) | 3,792 | 2,695 | 4,639 | (52,563) | ||
| Fiscal Year - 1 | (118,270) | (78,928) | 84 | 6,455 | 2,974 | (28,797) | ||
| Fiscal Year - 2 | 12,639 | (141,585) | (1,119) | (388) | 611 | 10,684 | ||
| Fiscal Year - 3 | 8,103 | (99,705) | 6,368 | NA | (7,495) | 3,295 | ||
| Fiscal Year - 4 | 11,253 | (13,019) | 3,159 | NA | 9,404 | 26,960 | ||
| Fiscal Year - 5 | (8,315) | (13,444) | 5,528 | 3,051 | 5,285 | 34,929 | ||
| Total Assets | ||||||||
| Latest Fiscal Quarter Prior | 589,397 | 611,261 | 121,303 | 242,098 | 266,305 | 790,340 | ||
| Latest Fiscal Quarter | 590,984 | 589,043 | 112,387 | 303,437 | 283,887 | 788,555 | ||
| Fiscal Year | 590,984 | 589,043 | 112,387 | 303,437 | 283,887 | 788,555 | ||
| Fiscal Year - 1 | 589,397 | 611,261 | 121,303 | 242,098 | 266,305 | 790,340 | ||
| Fiscal Year - 2 | 684,140 | 655,810 | 130,947 | 213,260 | 240,545 | 871,106 | ||
| Fiscal Year - 3 | 614,621 | 708,970 | 129,401 | NA | 236,979 | 841,562 | ||
| Fiscal Year - 4 | 615,309 | 605,277 | 81,320 | NA | 253,239 | 818,927 | ||
| Fiscal Year - 5 | 365,283 | 612,723 | 66,747 | 192,243 | 237,817 | 748,667 | ||
| Fiscal Year - 6 | 217,062 | 564,669 | 62,231 | 114,380 | 221,623 | 652,616 | ||
| Common Equity | ||||||||
| Latest Fiscal Quarter Prior | 368,691 | 169,543 | 68,582 | 190,233 | 144,381 | 338,732 | ||
| Latest Fiscal Quarter | 378,491 | 160,758 | 71,441 | 189,542 | 146,154 | 287,262 | ||
| Fiscal Year | 378,491 | 160,758 | 71,441 | 189,542 | 146,154 | 287,262 | ||
| Fiscal Year - 1 | 368,691 | 169,543 | 68,582 | 190,233 | 144,381 | 338,732 | ||
| Fiscal Year - 2 | 426,521 | 191,244 | 59,815 | 184,953 | 143,704 | 379,812 | ||
| Fiscal Year - 3 | 507,939 | 152,909 | 57,467 | NA | 145,701 | 383,996 | ||
| Fiscal Year - 4 | 505,395 | 254,547 | 46,502 | NA | 156,057 | 381,298 | ||
| Fiscal Year - 5 | 246,343 | 252,892 | 26,598 | 180,158 | 149,164 | 340,744 | ||
| Fiscal Year - 6 | 150,511 | 276,825 | 22,241 | 103,982 | 149,012 | 307,380 | ||